The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis.
<h4>Background</h4>Giant cell arteritis (GCA) and Takayasu's arteritis (TAA) are large vessel vasculitides (LVV) for which corticosteroids (CS) are the mainstay for treatment. In patients with LVV unable to tolerate CS, biological agents have been used with variable effectiveness.&l...
Saved in:
| Main Authors: | Mohammed Osman, Christian Pagnoux, Donna M Dryden, Dale Storie, Elaine Yacyshyn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0115026 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis.
by: Siyuan Chen, et al.
Published: (2025-01-01) -
Vasculitis mimics. Part 2. Large and medium vessel vasculitis mimickers: genetic vasculopathies. Mimickers of small vessel vasculitis
by: G. M. Tarasova, et al.
Published: (2025-06-01) -
Current imaging techniques in large vessel vasculitis
by: T. V. Beketova, et al.
Published: (2022-03-01) -
Review of guideline for the management of large vessel vasculitis presented in 2021 by the American College of Rheumatology / Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2022-05-01) -
Mimickers of vasculitis. Part I. Large and medium vessel vasculitis mimickers: infections, non-genetic vasculopathy
by: G. M. Tarasova, et al.
Published: (2025-04-01)